Results 121 to 130 of about 4,991 (157)

Effects of cutaneous leishmaniasis on health-related quality of life: A longitudinal approach. [PDF]

PLoS One
Galvão EL, Carvalho JP, Machado de Assis TS, Cota G, Silva SN.   +4 more
europepmc   +1 more source

Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU. [PDF]

United European Gastroenterol J
Madero-Velázquez L, Mínguez A, Mayorga L, Ramírez JJ, Moreno N, Amorós C, Nieto MA, Mena R, Benítez JM, Gimeno-Pitarch L, Maroto N, Suria C, Rodríguez-Moranta F, Ordás I, Ruiz L, García-Brenes MA, Martín-Cardona A, de Célix CR, Cárdenas K, Ginard D, Medina L, Pedrero N, Plaza R, Salmoral R, Martínez-Pérez TJ, Algara V, Merino E, Zabana Y, Gutiérrez A, Young Group of GETECCU.   +29 more
europepmc   +1 more source

How Common Is Imported Cutaneous Leishmaniasis in Romania? Two Case Reports. [PDF]

Microorganisms
Birlutiu V, Iancu G, Birlutiu RM, Florescu SA.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mucocutaneous leishmaniasis (espundia)

Postgraduate Medical Journal, 2020
An 89-year-old Spanish man presented with a 15-month history of a slowly growing inflammatory lesion in his left nasolabial region (figure 1A). The process was slightly painful and pruritic. The patient was otherwise asymptomatic. A CT/positron emission tomography showed hypermetabolism in the affected …
Bernardino Roca, Manuel Roca
openaire   +2 more sources

Imported mucocutaneous leishmaniasis

Clinical and Experimental Dermatology, 1996
We report a case of mucocutaneous leishmaniasis in a otherwise fit Caucasian man who had traveled in an endemic area. Initial tissue microscopy failed to identify the causative organism, which was only determined by subsequent culture as Leishmania braziliensis.
J L, Rosbotham, E L, Corbett, H R, Grant, R J, Hay, A D, Bryceson   +4 more
openaire   +2 more sources

Cutaneous and Mucocutaneous Leishmaniasis

Infectious Disease Clinics of North America, 2012
Tegumentary leishmaniases are caused by approximately 15 species of protozoa of the genus Leishmania. They prevail in tropical and subtropical areas of the Old and New World but human mobility also makes them a medical problem in nonendemic areas. Clinical manifestations may comprise cutaneous and mucocutaneous forms that may be localized, disseminated,
Hiro, Goto, José Angelo, Lauletta Lindoso   +1 more
openaire   +2 more sources

Mucocutaneous Leishmaniasis and HIV

Dermatology, 1994
Mucocutaneous leishmaniasis is a rare disease in Europe. Relapses after treatment are more frequent than in visceral leishmaniasis. HIV patients infected by Leishmania have frequently visceral involvement, and responses to treatment are poor. Mucocutaneous leishmaniasis in HIV-infected patients has rarely been reported.
E S, Miralles, M, Núñez, Y, Hilara, A, Harto, R, Moreno, A, Ledo   +5 more
openaire   +2 more sources

American Mucocutaneous Leishmaniasis

Southern Medical Journal, 1977
Presented is a well-documented, autochthonous case of mucocutaneous leishmaniasis, a protozoan disease endemic to Asia, Africa, Southern Europe, South America, and Central America, which until recently was not found in North America. Diagnosis is made by positive culture on NNN media, positive serodiagnosis, positive Montenegro skin test, the presence ...
D, Barlow, M, Lonergan, F O, Tio, W L, Meyerhoff   +3 more
openaire   +2 more sources